---
$id: https://graph.org.ai/products/commodity/51111649
$type: Product
source: UNSPSC
code: "51111649"
title: "Peldesine"
class: "51111600"
classTitle: "Antimetabolites"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Peldesine

**UNSPSC Code**: 51111649
**Class**: [Antimetabolites](Antimetabolites.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a purine nucleoside phosphorylase inhibitor with the molecular formula C12H11N5O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7B646RJ70F, chemically known as 4h-pyrrolo(3,2-d)pyrimidin-4-one, 2-amino-3,5-dihydro-7-(3-pyridinylmethyl)- but generally known as peldesine, which bears US NIH Compound Identifier 60817. European Medicines Agency schedules Peldesine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09649MIG. The term PELDESINE is an International Non-Proprietary Name. PELDESINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule peldesine under HS 29335995 and SITC 51576. As of Q4 2014, PELDESINE remains the US FDA Preferred Term for this commodity. Peldesine bears US NLM identifiers UMLS ID C0338278 and NCI Concept Code C1650. SMILES: C1=CC(=CN=C1)CC2=CNC3=C2NC(=NC3=O)N.

